Katie Devine is the Associate Director of the New Jersey Pediatric Hematology and Oncology Research Center of Excellence (NJPHORCE) at Rutgers Cancer Institute and an Associate Professor of Pediatrics and the Section Chief of Pediatric Population Science, Outcomes, and Disparities Research in the Division of Pediatric Hematology/Oncology at Rutgers Robert Wood Johnson Medical School.
The Devine Research Program focuses on the psychosocial aspects of pediatric, adolescent, and young adult cancer survivorship, including patient and family adaptation to illness, adherence to medical recommendations and survivorship care, healthcare transitions, and health promotion for survivors.
Investigators at Rutgers Cancer Institute of New Jersey have developed a novel approach for utilizing 4-dimensional (4D) printing of arrays for rapid programmable drug testing.
9:00 AM-6:00 PM
McDonnell Hall
Washington Road, Princeton University, Princeton, NJ, 08540
Researchers have received a five-year, $4.6 million grant from the National Institutes of Health (NIH) to determine how chemotherapy exerts its damaging effects on the brain. Read more
